From this presentation, one will learn:

  • Characteristics of DCTs and hybrid trials and how these differ from virtual trials
  • A spectrum of approaches to DCTs, how they help patients, and the impact of the pandemic on adoption of remote approaches
  • About SDR and how it aligns with risk-based monitoring and differs from source data verification (SDV)
  • How a systems approach to clinical research and standards can support DCTs
  • Opportunities to leverage eSource technology and a clinical control layer to actualize DCTs and SDR



When you need direct access to physicians and their known patients or research practice management solutions to accelerate your clinical trials, there’s Only Elligo.

Contact Us